Maxim Group Reiterates Buy on Palisade Bio, Maintains $22.5 Price Target
Portfolio Pulse from Benzinga Newsdesk
Maxim Group analyst Naz Rahman has reiterated a Buy rating on Palisade Bio (NASDAQ:PALI) and maintained a $22.5 price target.
May 01, 2024 | 4:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Maxim Group analyst Naz Rahman reiterates a Buy rating on Palisade Bio with a $22.5 price target.
The reiteration of a Buy rating and a maintained price target of $22.5 by a Maxim Group analyst suggests a strong bullish outlook on Palisade Bio. This endorsement could positively influence investor sentiment and potentially drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100